Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls

The study assessed long-term immunopersistence and safety of the Escherichia coli (E. coli)-produced HPV-16/18 bivalent vaccine. In total, 979 participants in the initial immunogenicity noninferiority study, including girls aged 9-14 years who were randomized in a 1:1 ratio to receive 2 doses at mon...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xingmei Yao, Wengang He, Xianghong Wu, Jianxiang Gu, Jing Zhang, Bizhen Lin, Zhaofeng Bi, Yingying Su, Shoujie Huang, Yuemei Hu, Ting Wu, Jun Zhang, Ningshao Xia
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2022-11-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	human papillomavirus vaccine escherichia coli-produced adolescent girl immunopersistence
Accés en línia:	http://dx.doi.org/10.1080/21645515.2022.2061248
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!